[1]
Dönmez Çakıl, Y. et al. 2023. The effects of low-dose sorafenib on epithelial-mesenchymal transition and multidrug resistance markers in HepG2 cell line. The European Research Journal. 9, 2 (Mar. 2023), 367–374. DOI:https://doi.org/10.18621/eurj.1206680.